Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The PhINEST Study - Pharyngeal ICU Novel Electrical Stimulation Therapy

NCT: NCT03840395 · TERMINATED

NCT IDNCT03840395
StatusTERMINATED
Start Date2019-06-17
Completion2025-12-31
SponsorPhagenesis Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, multi-site, randomised, sham-controlled, single-blind (outcome assessor-blinded) study designed to assess the effects of Pharyngeal Electrical Stimulation (PES) (using Phagenyx®) for the treatment of oropharyngeal dysphagia after invasive mechanical ventilation (of any duration) by means of naso or oro-tracheal tube in critically ill intensive care unit (ICU) patients.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑